ACADIA PHARMACEUTICALS INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $782.6M
Liabilities Breakdown FY2020
Total Liabilities: $155.6M
Asset Breakdown
Total Assets: $782.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $326.0M | 41.7% |
| Accounts Receivable | $48.2M | 6.2% |
| Inventory | $9.7M | 1.2% |
| Property, Plant & Equipment | $9.2M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.1M | 0.1% |
| Other Assets | $388.4M | 49.6% |
Liabilities Breakdown
Total Liabilities: $155.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.5M | 5.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $147.1M | 94.5% |